SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

44

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

44

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

44

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

44

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

44

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

Search

Carl Zeiss Meditec AG

Gesloten

SectorGezondheidszorg

40.22 1.21

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

40

Max

40.62

Belangrijke statistieken

By Trading Economics

Inkomsten

-17M

28M

Verkoop

-10M

550M

K/W

Sectorgemiddelde

24.936

77.671

Dividendrendement

1.38

Winstmarge

5.163

Werknemers

5,730

EBITDA

-25M

48M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+22.98% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.38%

2.35%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

63M

3.7B

Vorige openingsprijs

39.01

Vorige sluitingsprijs

40.22

Nieuwssentiment

By Acuity

48%

52%

164 / 374 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

Carl Zeiss Meditec AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

8 apr 2025, 08:20 UTC

Marktinformatie

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Peer Vergelijking

Prijswijziging

Carl Zeiss Meditec AG Prognose

Koersdoel

By TipRanks

22.98% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 49.19 EUR  22.98%

Hoogste 60 EUR

Laagste 35.1 EUR

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Carl Zeiss Meditec AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

3

Buy

4

Hold

1

Sell

Technische score

By Trading Central

58.75 / 60.35Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Strong Bullish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

164 / 374 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.
help-icon Live chat